Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Sales | 32 | 116 | 19 | 12 | 3 |
| Cost of Goods | 17 | 80 | 10 | 6 | 1 |
| Gross Profit | 16 | 36 | 9 | 7 | 2 |
| Operating Expenses | 1,841 | 1,460 | 1,710 | 1,337 | 1,230 |
| Operating Income | -1,809 | -1,344 | -1,698 | -1,318 | -1,227 |
| Interest Expense | 2 | 0 | 0 | 0 | 0 |
| Other Income | 59 | 53 | 44 | 11 | 18 |
| Pre-tax Income | -1,751 | -1,291 | -1,654 | -1,307 | -1,210 |
| Net Income Continuous | -1,751 | -1,291 | -1,654 | -1,307 | -1,210 |
| Net Income | $-1,751 | $-1,291 | $-1,661 | $-1,300 | $-1,210 |
| EPS Basic Total Ops | -79.00 | -6.00 | -7.00 | -7.00 | -9.00 |
| EPS Basic Continuous Ops | -78.93 | -5.83 | -8.00 | -7.13 | -7.49 |
| EPS Diluted Total Ops | -79.00 | -6.00 | -7.00 | -7.00 | -9.00 |
| EPS Diluted Continuous Ops | -78.93 | -5.83 | -8.00 | -7.13 | -7.49 |
| EBITDA(a) | $-1,766 | $-1,303 | $-1,651 | $-1,286 | $-1,185 |